Skip to main content
SpringerLink
Log in

Oncocytic Cell Tumors of the Thyroid: Factors Predicting Malignancy and Influencing Prognosis, Treatment Decisions, and Outcomes

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The distinction between malignant and benign thyroid oncocytic cell tumors (OCTs) before and during surgery still represents a diagnostic challenge. We focused on the search for specific factors that predict malignancy and influence the prognosis of OCTs, and for their most appropriate management.

Methods

From January 1998 to May 2007, 57 patients underwent thyroidectomy in our surgical department because of OCT. A cross-sectional study of 28 patients with carcinoma and 29 patients with adenoma was performed: demographic data, tumor characteristics, diagnostic results, patient management, postoperative, and follow-up results were evaluated.

Results

The prevalence of malignancy was 49.1%. The mean tumor size was significantly greater for carcinomas than for adenomas (3.0 cm vs. 1.8 cm; p = 0.003). Threshold sizes of more than 3.0 cm and 4.0 cm were significant for predicting malignancy (p = 0.020 and p = 0.010, respectively). Tumor multifocality, microfollicular features, and severe cytological atypia also were significantly related to malignancy (p = 0.012 and p = 0.025, respectively). Recurrent OCT was observed in three patients with carcinoma. One patient with distant metastases died from the disease. Older age, tumor size, thyroid capsular invasion, higher TNM stage, and AMES high risk were factors significantly related to tumor recurrence. Multivariate analysis showed that larger tumor size was the only factor predictive of malignancy and influencing recurrence.

Conclusions

All OCTs should be referred to surgery because of the high prevalence of malignancy. In the case of OCTs with larger tumor size and microfollicular features with severe cytological atypia, total thyroidectomy is strongly recommended as initial treatment also in relation with the more likely aggressive biological behavior of greater tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Carcangiu ML, Bianchi S, Savino D et al (1991) Follicular Hürthle cell tumors of the thyroid gland. Cancer 68:1944–1953

    Article  CAS  PubMed  Google Scholar 

  2. DeLellis RA, Lloyd RV, Heitz PU et al (2004) World health organization classification of tumors pathology & genetics tumors of endocrine organs. IARC Press, Lyon, pp 69–72

    Google Scholar 

  3. LiVolsi VA (1990) Surgical pathology of the thyroid. Saunders, Philadelphia, pp 188–193

    Google Scholar 

  4. McLeod MK, Thompson NW (1990) Hürthle cell neoplasms of the thyroid. Otolaryngol Clin North Am 23:441–452

    CAS  PubMed  Google Scholar 

  5. Chen H, Udelsman R (1997) Hürthle cell adenoma and carcinoma. In: Clark O, Duh QY (eds) Textbook of endocrine surgery. Saunders, Philadelphia, pp 103–107

    Google Scholar 

  6. Stojadinovic A, Hoos A, Ghossein RA et al (2002) Hürthle cell carcinoma: a 60-year experience. Ann Surg Oncol 9:197–203

    PubMed  Google Scholar 

  7. Hundahl SA, Fleming ID, Fremgen AM et al (1998) A national cancer data base report on 58, 856 cases of thyroid carcinoma treated in U.S., 1985–1995. Cancer 83:2638–2648

    Article  CAS  PubMed  Google Scholar 

  8. Hundahl SA, Cady B, Cunningham MP et al (2000) Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German thyroid cancer patient group. An American college of surgeons commission on cancer patient care evaluation study. Cancer 89:202–217

    Article  CAS  PubMed  Google Scholar 

  9. Chen H, Nicol TL, Udelsman R (1995) Follicular lesions of the thyroid: does frozen section evaluation alters operative management? Ann Surg 222:101–106

    Article  CAS  PubMed  Google Scholar 

  10. Chen H, Nicol TL, Ma Zeiger et al (1998) Hürthle cell neoplasm of the thyroid: are there factors predictive of malignancy? Ann Surg 227:542–546

    Article  CAS  PubMed  Google Scholar 

  11. Giorgadze T, Rossi ED, Fadda G et al (2004) Does the fine-needle aspiration diagnosis of Hürthle cell neoplasm/follicular neoplasm with oncocytic features denote increased risk of malignancy? Diagn Cytopathol 31:307–312

    Article  PubMed  Google Scholar 

  12. Alaedeen DI, Khiyami A, McHenry CR (2005) Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease. Surgery 138:650–657

    Article  PubMed  Google Scholar 

  13. Elliott DD, Pitman MB, Bloom L et al (2006) Fine-needle aspiration biopsy of Hürthle cell lesions of the thyroid gland. A cytomorphologic study of 139 cases with statistical analysis. Cancer Cytopathol 108:102–109

    Google Scholar 

  14. Thompson NW, Dunn EL, Batsakis JG et al (1974) Hürthle cell lesions of the thyroid gland. Surg Gynecol Obstet 139:555–560

    CAS  PubMed  Google Scholar 

  15. Bondeson L, Bondeson AG, Ljungberg O et al (1981) Oxyphilic tumors of the thyroid: follow up of 42 surgical cases. Ann Surg 194:677–680

    Article  CAS  PubMed  Google Scholar 

  16. Gundry SR, Burney RE, Thompson NW et al (1983) TT for Hürthle cell neoplasms of the thyroid. Arch Surg 118:529–533

    CAS  PubMed  Google Scholar 

  17. McDonald MP, Sanders LE, Silverman ML et al (1996) Hürthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery 120:1000–1005

    Article  CAS  PubMed  Google Scholar 

  18. Khafif A, Khafif RA, Attie JN (1999) Hürthle cell carcinoma: a malignancy of low-grade potential. Head Neck 21:506–511

    Article  CAS  PubMed  Google Scholar 

  19. Caplan RH, Abellera RM, Kisken WA (1984) Hürthle cell tumors of the thyroid gland: a clinicopathologic review and long-term follow up. JAMA 251:3114–3117

    Article  CAS  PubMed  Google Scholar 

  20. Lopez-Penabad L, Chiu AC, Hoff AO et al (2003) Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer 97:1186–1194

    Article  PubMed  Google Scholar 

  21. Pisanu A, Sias L, Uccheddu A (2004) Factors predicting malignancy of Hürthle cell tumors of the thyroid: influence on surgical treatment. World J Surg 28:761–765

    Article  PubMed  Google Scholar 

  22. Cady B, Rossi R, Silverman M et al (1985) Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery 98:1171–1178

    CAS  PubMed  Google Scholar 

  23. Shah JP, Kian K, Forastiere A et al (2002) Thyroid gland. In: American joint committee on cancer: cancer staging manual 2002, 6th edn. New York, Springer–Verlag, pp 77–87

  24. Chao TC, Lin JD, Chen MF (2005) Surgical treatment of Hürthle cell tumors of the thyroid. World J Surg 29:164–168

    Article  PubMed  Google Scholar 

  25. Hedinger C, Williams ED, Sobin LH (1988) Histological typing of thyroid tumors. In: International histological classification of tumors, 2nd edn, World Health Organization. Springer Verlag, New York

    Google Scholar 

  26. Rosai J, Carcangiu ML, DeLellis RA (1992) Tumors of the thyroid gland: atlas of tumor pathology. 3rd series, fascicle 5. Armed Forces Institute of Pathology, Washington DC

    Google Scholar 

  27. Kushchayeva Y, Duh QY, Kebevew E et al (2008) Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hürthle cell or follicular thyroid cancer. Am J Surg 195:457–462

    Article  PubMed  Google Scholar 

  28. Musholt PB, Imkamp F, Von Wasielewski R et al (2003) RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinoma? Surgery 134:881–889

    Article  PubMed  Google Scholar 

  29. Maxwell LE, Palme CE, Freeman J (2006) Hürthle cell tumors. Applying molecular markers to define a new management algorithm. Arch Otolaryngol Head Neck Surg 132:54–58

    Article  PubMed  Google Scholar 

  30. Kushchayeva Y, Duh QY, Kebebew E et al (2004) Prognostic indications for Hürthle cell cancer. World J Surg 28:1266–1270

    Article  PubMed  Google Scholar 

  31. Foote RL, Brown PD, Garces YI et al (2003) Is there a role for radiation therapy in the management of Hürthle cell carcinoma? Int J Radiation Oncology Biol Phys 56:1067–1072

    Article  Google Scholar 

  32. McIvor NP, Freeman JL, Rosen I et al (1993) Value of fine needle aspiration in diagnosis of Hürthle cell neoplasms. Head Neck 15:335–341

    Article  CAS  PubMed  Google Scholar 

  33. Gosain AK, Clark OH (1984) Hürthle cell neoplasms. Arch Surg 118:529–532

    Google Scholar 

  34. Azadian A, Rosen IB, Walfish PG et al (2005) Management considerations in Hürthle cell carcinoma. Surgery 118:711–715

    Article  Google Scholar 

  35. Wsavary H, Czako P, Poulik J et al (1998) Unilateral lobectomy for Hürthle cell adenoma. Am Surg 64:729–733

    Google Scholar 

  36. Janser JC, Solis C, Rodier JF et al (1996) Les cancers oncocytaires de la thyroïde: cancers à cellules de Hürthle. Chirurgie 121:28–36

    CAS  PubMed  Google Scholar 

  37. Sugino K, Ito K, Mimura T et al (2001) Hürthle cell tumors of the thyroid: analysis of 188 cases. World J Surg 25:1160–1163

    CAS  PubMed  Google Scholar 

  38. Rosen IB, Luk S, Katz I (1985) Hürthle cell tumors behavior: dilemma and resolution. Surgery 98:777–783

    CAS  PubMed  Google Scholar 

  39. Heppe H, Armin A, Calandra DB et al (1985) Hürthle cell tumors of the thyroid gland. Surgery 98:1162–1165

    CAS  PubMed  Google Scholar 

  40. Arganini M, Behar R, Wu TC et al (1986) Hürthle cell tumors: a twenty-five years experience. Surgery 100:1108–1115

    CAS  PubMed  Google Scholar 

  41. Marzano LA, Finelli L, Marranzini A et al (1989) Hürthle cell neoplasms. Int Surg 74:97–98

    CAS  PubMed  Google Scholar 

  42. Dahl LD, Myssiorek D, Heller KS (2002) Hürthle cell neoplasms of the thyroid. Laryngoscope 112:2178–2180

    Article  PubMed  Google Scholar 

  43. McHenry CR, Thomas SR, Slusarczyk SJ et al (1999) Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? Surgery 126:798–802

    CAS  PubMed  Google Scholar 

  44. Paunovic I, Krgovic K, Tatic S et al (2006) Surgery for thyroid Hürthle cell tumours: a single institution experience. Eur J Surg Oncol 32:458–461

    Article  CAS  PubMed  Google Scholar 

  45. Melck A, Bugis S, Baliski C et al (2006) Hemithyroidectomy: the preferred initial surgical approach for management of Hürthle cell neoplasm. Am J Surg 191:593–597

    Article  CAS  PubMed  Google Scholar 

  46. Sippel RS, Elaraj DM, Khanafshar E et al (2008) Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid. World J Surg 32:702–707

    Article  PubMed  Google Scholar 

  47. Bronner MP, Clevenger CV, Edmonds PR et al (1988) Flow cytometric analysis of DNA content in Hürthle cell adenomas and carcinomas of the thyroid. Am J Clin Pathol 89:764–769

    CAS  PubMed  Google Scholar 

  48. Zhang YW, Greenblatt DY, Repplinger D et al (2008) Older age and larger tumor size predict malignancy in Hürthle cell neoplasms of the thyroid. Ann Surg Oncol 15:2842–2846

    Article  PubMed  Google Scholar 

  49. Gonzales JL, Helen HW, Ducatman BS (1993) Fine-needle aspiration of Hürthle cell lesions: a cytomorphologic approach to diagnosis. Am J Clin Pathol 100:231–235

    Google Scholar 

  50. Renshaw AA (2002) Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid. Defining more consistent and specific cytologic criteria. Cancer 96:261–266

    Article  PubMed  Google Scholar 

  51. Wu HH, Clouse J, Ren R (2008) Fine-needle aspiration cytology of Hürthle cell carcinoma of the thyroid. Diagn Cytopathol 36:149–154

    Article  PubMed  Google Scholar 

  52. Fadda G, Balsamo G, Fiorino MC et al (1998) Follicular thyroid lesions and risk of malignancy: a new diagnostic classification on fine-needle aspiration cytology. J Exp Clin Cancer Res 17:103–107

    CAS  PubMed  Google Scholar 

  53. Boyd LA, Earnhardt RC, Dunn JT et al (1998) Preoperative evaluation and predictive value of fine-needle aspiration and frozen section of thyroid nodules. J Am Coll Surg 87:494–502

    Article  Google Scholar 

  54. Pu RT, Yang J, Wasserman PG et al (2006) Does Hürthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn Cytopathol 34:330–334

    Article  PubMed  Google Scholar 

  55. Paphavasit A, Thompson GB, Hay ID et al (1997) Follicular and Hürthle cell thyroid neoplasms: is frozen-section evaluation worthwhile? Arch Surg 132:674–680

    CAS  PubMed  Google Scholar 

  56. Udelsman R, Westra W, Donovan P et al (2001) Randomized prospective evaluation of frozen section analysis for follicular neoplasms of the thyroid. Ann Surg 233:716–722

    Article  CAS  PubMed  Google Scholar 

  57. Bronner MP, Hamilton R, LiVolsi VA (1994) Utility of frozen section on follicular lesions of the thyroid. Endocrinol Pathol 5:154–161

    Article  Google Scholar 

  58. Besic N, Vidergar-Kralj B, Frkovic-Grazio S et al (2003) The role of radioactive iodine in the treatment of Hürthle cell carcinoma of the thyroid. Thyroid 13:577–584

    Article  CAS  PubMed  Google Scholar 

  59. Wartofsky L, Sherman SI, Gopal J et al (1998) The use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 83:4195–4199

    Article  CAS  PubMed  Google Scholar 

  60. Pryma DA, Schoder H, Gonen M et al (2006) Diagnostic accuracy and prognostic value of 18-F-FDG PET in Hürthle cell thyroid cancer patients. J Nucl Med 47:1260–1266

    PubMed  Google Scholar 

  61. Plotkin M, Hautzel H, Krause BJ et al (2002) Implication of 2–18fluor-2-deoxyglucose positron emission tomography in the follow up of Hürthle cell thyroid cancer. Thyroid 12:155–161

    Article  PubMed  Google Scholar 

  62. Mirallie E, Guillan T, Bridji B et al (2007) Therapeutic impact of 18 FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma. Surgery 142:952–958

    Article  PubMed  Google Scholar 

  63. Shaha AR, Shah JP, Loree TR (1996) Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg 172:692–694

    Article  CAS  PubMed  Google Scholar 

  64. Grossman RF, Clark OH (1997) Hürthle cell carcinoma. Cancer Control 4:13–17

    PubMed  Google Scholar 

  65. Ruegemer JJ, Hay ID, Bergstralh EJ et al (1988) Distant metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab 67:501–508

    Article  CAS  PubMed  Google Scholar 

  66. Erickson LA, Jin L, Goellner JR et al (2000) Pathologic features, proliferative activity, and cyclin D1 expression in Hürthle cell neoplasms of the thyroid. Mod Pathol 13:186–192

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the University of Cagliari, Cagliari, Italy.

Author information

Authors and Affiliations

  1. Department of Surgery, Clinica Chirurgica, University of Cagliari, Ospedale San Giovanni di Dio, Via Ospedale 46, 09124, Cagliari, Italy

    Adolfo Pisanu, Barbara Di Chiara, Isabella Reccia & Alessandro Uccheddu

Authors
  1. Adolfo Pisanu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Di Chiara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Isabella Reccia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alessandro Uccheddu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adolfo Pisanu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pisanu, A., Di Chiara, B., Reccia, I. et al. Oncocytic Cell Tumors of the Thyroid: Factors Predicting Malignancy and Influencing Prognosis, Treatment Decisions, and Outcomes. World J Surg 34, 836–843 (2010). https://doi.org/10.1007/s00268-009-0357-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-009-0357-z

Keywords

Search

Navigation